Optimizing ctDNA-based MRD Assessment in DLBCL, MCL, and FL Patients Undergoing CAR Therapy

Clinical trial NCT05255354 · RECRUITING

Trial details

NCT number: NCT05255354
Sponsor: Adaptive Biotechnologies
Status: RECRUITING
Study type: OBSERVATIONAL

Follicular Lymphoma Diffuse Large B Cell Lymphoma Mantle Cell Lymphoma

Start date: 2022-06-01
Primary completion: 2025-09-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.